Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Philips Collaboration Live integrated tele-ultrasound expands FDA 510(k) clearance for remote diagnostic use to additional mobile platforms

Philips Respironics provides update for the US on ongoing CPAP, BiPAP and Mechanical Ventilator field action

STAMFORD, Conn., March 10, 2022 /PRNewswire/ -- Philips, a global leader in health technology, announced today its latest effort to empower guys to live healthier, happier lives by looking and feeling their best with the launch of Philips Norelco OneBlade First Shave.

Philips partners with basketball legend Grant Hill to celebrate the launch of Philips Norelco OneBlade First Shave

Philips recognized in 2021 Gartner® Market Guide for Digital Health Platforms

New post-cryptogenic stroke remote telemetry study demonstrates increased atrial fibrillation detection and USD 4 million in cost savings using initial Philips BioTel Heart MCOT monitoring

Health technology leader Philips on track with its Environmental, Social, and Governance commitments

Philips publishes its Annual Report 2021

Philips Enterprise Viewer – Vue Motion – vendor neutral image viewer and Philips EMR Tasy electronic medical record win ‘Best in KLAS' awards

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the company has once again been included in Forbes' “America's Best Employers of 2022” list. Philips is one of the top 10 Health Care Equipment & Services companies in the nation to make this year's list, which features 500 large companies from multiple industries. A complete list of companies named to Forbes' “America's Best Employers of 2022” is available at https

Forbes Names Philips a Top Place to Work in “America's Best Employers of 2022” Ranking

Philips expands access to hemodynamics at point-of-care for real-time blood flow assessment on Handheld Ultrasound – Lumify

Philips and University Hospital Brandenburg an der Havel sign 10-year partnership to advance patient care

The FDA has classified Koninklijke Philips NV's (NYSE: PHG) expanded recall of certain ventilators late last year as Class 1, or the most serious type of recall. According to the FDA announcement, a Philips supplier had incorrectly used the polyurethane foam, which is intended to reduce sound and vibration, in one of the parts of the Trilogy Evo ventilators.

Philips Recalls Trilogy Evo Ventilators, Repair Kits For Potential Health Risks

Philips introduces first at-home, 12-lead ECG integrated solution for decentralized clinical trials

Koninklijke Philips N.V.'s (PHG) CEO Frans van Houten on Q4 2021 Results - Earnings Call Transcript

Koninklijke Philips NV (NYSE: PHG) reported a fourth-quarter FY21 sales decline of 5.6% year-on-year to €4.9 billion. The company attributed the comparable sales decline of 10% to headwinds caused by global supply chain challenges, postponement of equipment installations in hospitals, and consequences of the Respironics field action.

Philips Registers 10% Comparable Sales Decline In Q4

Dutch health technology company Philips said on Monday it expects sales to recover strongly in the second half of the year, while a steep decline due to global shortages of parts is likely to persist in the coming months.

Philips expects sales to recover from supply chain woes after the summer

January 24, 2022 Fourth-quarter highlights

Philips delivers Q4 sales of EUR 4.9 billion and income from continuing operations of EUR 139 million; Adjusted EBITA margin amounts to 13.1%, operating cash flow is EUR 720 million; good demand drives mid-single-digit order intake growth

Phillips (PHG) integrates AI and 3D mapping capabilities it its Mobile C-Arm System, Zenition, enhancing its diagnostic imaging portfolio.

Phillips (PHG) Blends 3D Mapping With Zenition, Aids Prospects

Philips supports the American Heart Association's efforts to raise awareness of cardiovascular implantable electronic device (CIED) infections, promote guideline adherence, and improve patient survival rates

Philips integrates cloud-based AI and 3D mapping into its Mobile C-arm System Series – Zenition – to enhance workflow efficiency and improve endovascular treatment outcomes

Increased provisions for a product recall and the pandemic's impact on the installation of its medical equipment hurt the company in the fourth quarter.

Why Shares of Royal Philips Got Crushed Today

Philips (PHG) fourth-quarter and 2021 results suffer from supply-chain constraints and adverse impact of the Respironics recall.

Philips' (PHG) Q4 Earnings Hit By Supply-Chain Issues, Recall

The U.S.-listed shares of Koninklijke Philips N.V. PHG, -15.53% PHIA, -15.37% plunged 15.7% toward a near two-year low in morning trading Wednesday, after the Netherlands-based medical technologies and products company provided a downbeat revenue outlook, citing "intensified global supply chain shortages" and the postponement of customer equipment installations.

Philips stock tumbles toward biggest selloff since 2008 after downbeat revenue outlook

The shares of Koninklijke Philips NV (NYSE:PHG) are plummeting today, down 14.9% to trade at $32.97, after the medical equipment company issued a profit warning, saying it expected fourth-quarter core profit to drop nearly 40% amid supply issues.

Medical Equipment Stock Drops on Profit Warning, Recall Concerns

Shares of Koninklijke Philips NV (NYSE: PHG) slipped nearly 20% this morning after the health technology company predicted a 40% decline in Q4 core profit. Philips blames supply constraints Philips now forecast roughly $5.57 billion in comparable sales for its fiscal fourth quarter that translates to nearly $0.40 billion lower than its previous estimate.

Philips opened 15% down on Wednesday: here's the catalyst

News for Royal Philips Stock (PHG)